SR

Sachin Rajesh Kelanka

Active Director Designated Partner DIN 11072797
DIN 11072797 First appointment Apr 2025
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Sachin Rajesh Kelanka

Data last updated:

Sachin Rajesh Kelanka is a Designated Partner at Klp Healthcare Multispeciality Hospital & Trauma Center Llp (since 2025).

DIN 11072797
Primary Designation Designated Partner
First Appointment 24 Apr 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner24 Apr 20252025Active

Board colleagues of Sachin Rajesh Kelanka

Directorship timeline

Open interactive timeline →
Klp Healthcare Multispeciality Hospital & Trauma Center Llp
Premium access

Shareholding and investment profile for Sachin Rajesh Kelanka

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sachin Rajesh Kelanka

Sachin Rajesh Kelanka currently holds 1 directorship: Klp Healthcare Multispeciality Hospital & Trauma Center Llp (Designated Partner, since 24 Apr 2025).

Sachin Rajesh Kelanka was first appointed on 24 Apr 2025 as Designated Partner at Klp Healthcare Multispeciality Hospital & Trauma Center Llp.

The current boards of Sachin Rajesh Kelanka's companies include Bhuwan Chandrakishor Lanjewar (Klp Healthcare Multispeciality Hospital & Trauma Center Llp), Manish Pandhare (Klp Healthcare Multispeciality Hospital & Trauma Center Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available